Primary cell CRISPR screens to accelerate drug discovery and target selection at single-cell resolution
Myllia Biotechnology
Loading...
Stefanie is heading to Berlin to represent Myllia at Discovery & Development Europe 2026
She will present a poster on how pooled CRISPR screenings were combined with InTraSeq, a single-cell method that measures RNA alongside intracellular and surface proteins.
🔗 shorturl.at/2XihX @cellsignal.com
Myllia is attending SLAS Europe in Vienna!
May 19th - Henrik, our VP Commercial, will present Myllia's high-content CRISPR screening platform.
May 20th - Tilmann, CSO, will showcase how our VISTA platform deciphers primary human macrophage biology.
🔗https://shorturl.at/PEbuc
Two weeks to our Element Biosciences webinar! Tillmann Burckstummer and Jens Durruthy Durruthy will take the stage to discuss how optical pooled CRISPR screens revealed NF-kB regulators in human cells.
📅 June 10th
🕑09:00 PDT/ 12:00 EDT/ 16:00 GMT
🔗https://shorturl.at/3DGEf
Join us on June 16th at 2PM CET for a hybrid seminar with Element Biosciences! Molly He, Matthew Gow, and Tillmann Burckstümmer will discuss single-cell multiomics, NGS, and how optical pooled CRISPR screening identified NF-κB regulators in human cells
Learn more and register: shorturl.at/6VQkD
Read the full PR here: www.biospace.com/press-releas...
We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place from March 18–19, 2026, in Vienna, Austria. The early-bird registration is open via the conference website:
www.perturb2026.bio
Meet the Speaker: Sami Farhi
We’re heading to #BIO2026!
Connect with Myllia as we share how our high-content CRISPR screening technology can fuel drug target discovery. Stay tuned for more details on where to find us and what we’ll be showcasing.
Book a meeting with us: convention.bio.org/partner
🚀 Are you ready to push the boundaries of bio AI foundation models? @mylliabio.bsky.social is thrilled to host "Echoes of Silenced Genes" - A Global Community Prediction Competition!
🔗 Learn more here and join the competition:
myllia.com/events/commu...
#AI #BioAI #CRISPR #Perturb2026
Meet Myllia Biotechnology at #CIMT2026 in Mainz 🇩🇪
Our Assoc. Director of R&D, Sumit, will present on pooled CRISPR screening for drug target discovery in primary human macrophages—highlighting our VISTA platform.
📅 May 11–13
👉 myllia.com/events/cimt-...
Myllia Biotechnology
Kick off 2026 with a deep dive into single-cell science! 🚀
Join FGCZ & BD Biosciences on March 9 in Zurich for the BD Rhapsody™ Science Days.
Featuring:
🔬 Dr. Simone Picelli (IOB, Basel)
🧬 @mylliabio.bsky.social
🩺 Dr. Marc Beyer (DZNE, Bonn)
✨ Dr. Luciano Martelotto (BD)
🔗 tinyurl.com/wbffw5an
